Integrated human organ-on-chip microphysiological systems
US-2015004077-A1 · Jan 1, 2015 · US
US10961496B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10961496-B2 |
| Application number | US-201615781370-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 2, 2016 |
| Priority date | Dec 4, 2015 |
| Publication date | Mar 30, 2021 |
| Grant date | Mar 30, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A microfluidic device is contemplated comprising an open-top cavity with structural anchors on the vertical wall surfaces that serve to prevent gel shrinkage-induced delamination, a porous membrane (optionally stretchable) positioned in the middle over a microfluidic channel(s). The device is particularly suited to the growth of cells mimicking dermal layers.
Opening claim text (preview).
The invention claimed is: 1. A method comprising: a) providing a microfluidic device for cell culture comprising i) an open-top cavity said cavity comprising ii) a gel matrix secured by structural anchors on the vertical wall surfaces, said gel matrix positioned above iii) a porous membrane, said membrane positioned above one or more iv) microfluidic channels and v) an actuation mechanism attached to the microfluidic device, said open-top cavity comprising vi) at least one open region in an open-top structure configured to allow direct access to the gel matrix and the membrane; and b) stretching said gel matrix with the actuation mechanism. 2. The method of claim 1 , wherein the gel matrix has a thickness of between 0.5 mm and 3.5 mm. 3. The method of claim 2 , wherein said stretching is uniform across the thickness of the gel. 4. The method of claim 1 , wherein said stretching causes the entire gel matrix to expand. 5. The method of claim 1 , wherein said gel matrix comprises cells. 6. The method of claim 5 , wherein said cells comprise lung cells. 7. The method of claim 1 , wherein said actuation device mechanism is a mechanical engaging device. 8. A method comprising: a) providing a microfluidic device for cell culture comprising i) an open-top cavity said cavity comprising ii) a gel matrix secured by structural anchors on the vertical wall surfaces, said gel matrix positioned above iii) a porous membrane, said membrane positioned above one or more iv) microfluidic channels, said open-top cavity comprising v) at least one open region in an open-top structure configured to allow direct access to the gel matrix and the membrane; and b) closing said open-top cavity with a removable lid. 9. The method of claim 8 , further comprising; c) removing the lid; and d) introducing cells to the gel matrix.
for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics · CPC title
involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025) · CPC title
with means providing thin layers · CPC title
by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip · CPC title
Apparatus specially adapted for solid-phase testing · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.